|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
36.000 -1.600 (-4.255%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 9,953,216 | 16.083% | 8,574,214 | 8,492,046 | 7,206,440 | 4,406,754 |
| Cost of Sales | (5,700,364) | 9.113% | (5,224,263) | (4,931,412) | (3,793,233) | (2,109,921) |
| Gross Profit | 4,252,852 | 26.953% | 3,349,951 | 3,560,634 | 3,413,207 | 2,296,833 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (133,843) | -29.619% | (190,170) | (131,797) | (70,838) | (133,166) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 3,328,101 | 65.711% | 2,008,377 | 2,528,976 | 2,930,135 | 2,058,228 | |
| Taxation | (571,490) | 150.580% | (228,067) | (191,116) | (308,910) | (175,450) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (417,345) | 48.400% | (281,230) | (71,185) | (86,161) | (40,638) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,339,266 | 56.047% | 1,499,080 | 2,266,675 | 2,535,064 | 1,842,140 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (91,814) | -25.910% | (123,922) | 3,976 | (21,343) | (5,415) |
| Depreciation & Amortisation | 854,474 | 9.018% | 783,792 | 668,491 | 500,955 | 332,131 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 58.000 | 56.757% | 37.000 | 55.000 | 61.000 | 44.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 11.048 | -- | 9.789 | 8.883 | 8.083 | 7.839 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,339,266 |
| %Change | 56.047% |
| EPS / (LPS) | RMB 0.580 |
| NBV Per Share (¥) | RMB 11.048 |